Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

175 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Pharmacokinetic considerations for the therapeutic use of carnitine in hemodialysis patients.
Brass EP. Brass EP. Clin Ther. 1995 Mar-Apr;17(2):176-85; discussion 175. doi: 10.1016/0149-2918(95)80017-4. Clin Ther. 1995. PMID: 7614519 Review.
A systematic review and meta-analysis of propionyl-L-carnitine effects on exercise performance in patients with claudication.
Brass EP, Koster D, Hiatt WR, Amato A. Brass EP, et al. Vasc Med. 2013 Feb;18(1):3-12. doi: 10.1177/1358863X12467491. Epub 2013 Jan 15. Vasc Med. 2013. PMID: 23321261 Review.
Exercise capacity as a predictor of survival among ambulatory patients with end-stage renal disease.
Sietsema KE, Amato A, Adler SG, Brass EP. Sietsema KE, et al. Among authors: brass ep. Kidney Int. 2004 Feb;65(2):719-24. doi: 10.1111/j.1523-1755.2004.00411.x. Kidney Int. 2004. PMID: 14717947
Differential management of cardiovascular disease in ESRD by nephrologists and cardiologists.
Martirosyan HA, Brass EP, Mehrotra R, Adler SG; Cardio-Renal Responder Group and the Validation Cohort. Martirosyan HA, et al. Among authors: brass ep. Am J Kidney Dis. 2004 Aug;44(2):309-21. doi: 10.1053/j.ajkd.2004.04.036. Am J Kidney Dis. 2004. PMID: 15264190
Label development and the label comprehension study for over-the-counter drugs.
Brass EP, Weintraub M. Brass EP, et al. Clin Pharmacol Ther. 2003 Nov;74(5):406-12. doi: 10.1016/S0009-9236(03)00239-X. Clin Pharmacol Ther. 2003. PMID: 14586381 Review. No abstract available.
Impact on carnitine homeostasis of short-term treatment with the pivalate prodrug cefditoren pivoxil.
Brass EP, Mayer MD, Mulford DJ, Stickler TK, Hoppel CL. Brass EP, et al. Clin Pharmacol Ther. 2003 Apr;73(4):338-47. doi: 10.1016/s0009-9236(02)17636-3. Clin Pharmacol Ther. 2003. PMID: 12709724 Clinical Trial.
Pivalate-generating prodrugs and carnitine homeostasis in man.
Brass EP. Brass EP. Pharmacol Rev. 2002 Dec;54(4):589-98. doi: 10.1124/pr.54.4.589. Pharmacol Rev. 2002. PMID: 12429869 Review.
Clinical and demographic predictors of exercise capacity in end-stage renal disease.
Sietsema KE, Hiatt WR, Esler A, Adler S, Amato A, Brass EP. Sietsema KE, et al. Among authors: brass ep. Am J Kidney Dis. 2002 Jan;39(1):76-85. doi: 10.1053/ajkd.2002.29884. Am J Kidney Dis. 2002. PMID: 11774105
Peripheral arterial disease is not associated with an increased prevalence of intradialytic cramps in patients on maintenance hemodialysis.
Brass EP, Adler S, Sietsema KE, Amato A, Esler A, Hiatt WR. Brass EP, et al. Am J Nephrol. 2002 Sep-Dec;22(5-6):491-6. doi: 10.1159/000065285. Am J Nephrol. 2002. PMID: 12381949
Application of adaptive design and decision making to a phase II trial of a phosphodiesterase inhibitor for the treatment of intermittent claudication.
Lewis RJ, Connor JT, Teerlink JR, Murphy JR, Cooper LT, Hiatt WR, Brass EP. Lewis RJ, et al. Among authors: brass ep. Trials. 2011 May 25;12:134. doi: 10.1186/1745-6215-12-134. Trials. 2011. PMID: 21612611 Free PMC article. Clinical Trial.
175 results
Jump to page